DR. SHRUTI MURALI M.D NPI 1902241649

NPI Information

  • NPI: 1902241649
  • Provider Name: DR. SHRUTI MURALI, M.D
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 7501 OSLER DR STE 102
    TOWSON, MD
    ZIP 21204
  • Phone: (443) 427-5585

Map and Directions

Get Directions

NPI Details

DR. Shruti Murali, M.D is a medical oncology internal medicine in Towson, MD with 7 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Shruti Murali, M.D NPI is 1902241649. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

7501 OSLER DR STE 102
TOWSON, MD
ZIP 21204-733
Phone: (443) 427-5585
Fax: (410) 427-5592

The NPI 1902241649 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Uric acid level, blood (HCPCS:84550)
  • Glutamyltransferase (liver enzyme) level (HCPCS:82977)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Iron binding capacity (HCPCS:83550)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)

The enumeration date for this NPI number is 5/8/2013 and was last updated on 11/18/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal MedicineD86774MARYLANDNo
2207RX0202XInternal MedicineMedical OncologyD86774MARYLANDYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.